Blog
RSS FeedPosted by Michael Wonder on 14 Jun 2019
Ontario grants broader access to Spinraza (nusinersen) for patients living with spinal muscular atrophy
13 June 2019 - Ontario joins Saskatchewan and Quebec to give patients with spinal muscular atrophy broader access to Spinraza. ...
Posted by Michael Wonder on 13 Jun 2019
Canada should have universal, single-payer public pharmacare, says advisory council
12 June 2019 - Canada should have a national pharmacare program that is universal, single payer and public, says an ...
Posted by Michael Wonder on 12 Jun 2019
Ford government to fund Spinraza, world’s most expensive drug - with age caps
12 June 2019 - The Ford government today announced it will be covering the cost of the drug Spinraza for ...
Posted by Michael Wonder on 12 Jun 2019
Canada will move on new drug price rules in 'very near future': minister
13 June 2019 - Work on the Canadian government’s proposal to crack down on patented drug prices is underway and ...
Posted by Michael Wonder on 08 Jun 2019
'Equity issue:' Saskatchewan to fully cover cost of abortion drug Mifegymiso
7 June 2019 - Advocates are celebrating the Saskatchewan government's decision to fully fund the cost of the abortion drug ...
Posted by Michael Wonder on 06 Jun 2019
Patients, physicians raise concerns with BC biosimilar non-medical switching policy
6 June 2019 - On 27 May, the Government of British Columbia announced a policy that will forcibly switch thousands ...
Posted by Michael Wonder on 03 Jun 2019
Canada to limit scope of new drug price rules
29 May 2019 - The federal government has assured the pharmaceutical industry that new features of its plan to cut ...
Posted by Michael Wonder on 30 May 2019
Use of real world data sources for Canadian drug pricing and reimbursement decisions: stakeholder views and lessons for other countries
29 May 2019 - Canada has a long history of the use of clinical evidence to support health care decision making. ...
Posted by Michael Wonder on 29 May 2019
Canada told drug makers it would limit scope of some new price rules
29 May 2019 - The Canadian government has assured the pharmaceutical industry that new features of its plan to cut ...
Posted by Michael Wonder on 29 May 2019
Prices of Canadian generic medicines below international average
29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...
Posted by Michael Wonder on 28 May 2019
Canadian Biosimilars Forum applauds B.C. Government's landmark decision to enhance adoption of biosimilars and calls on remaining provinces to follow
27 May 2019 - The Canadian Biosimilars Forum today commends the Government of British Columbia for taking a decisive step ...
Posted by Michael Wonder on 28 May 2019
BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines
27 May 2019 - Biosimilars Initiative implementation could contribute to significant cost savings for the BC health care system. ...
Posted by Michael Wonder on 27 May 2019
B.C. becomes first province to force change to biosimilar drugs
27 May 2019 - The change will save the government nearly $100 million over the next three years. ...
Posted by Michael Wonder on 27 May 2019
'You disappointed us': Why is Canada opposing more transparency in drug prices?
25 May 2019 - Pharma industry says high prices are necessary to cover costs. Some nations want to see the data. ...
Posted by Michael Wonder on 24 May 2019
Liberals want to build their campaign around Pharmacare, but ignore where drugs would end up
23 May 2019 - Internal documents from within the Liberal Party recently showed that Ontario Liberal MPs want 2019’s election ...